Emerald Mutual Fund Advisers Trust’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-490,000
Closed -$1.66M – 244
2017
Q3
$1.66M Hold
490,000
– – 0.07% 208
2017
Q2
$1.21M Sell
490,000
-10,000
-2% -$24.6K 0.05% 212
2017
Q1
$1.33M Hold
500,000
– – 0.06% 200
2016
Q4
$1.79M Buy
+500,000
New +$2.23M 0.09% 176

Other funds holding APYX

Emerald Mutual Fund Advisers Trust's APYX Position: Q4 2017 in Review

Emerald Mutual Fund Advisers Trust sold out of Apyx Medical (APYX) in Q4 2017, closing a stake of 490,000 shares — an estimated $1.66M sold.

Emerald Mutual Fund Advisers Trust first reported a position in APYX in Q4 2016 and held it in 4 quarters. The position peaked at $1.79M in Q4 2016. 41 funds tracked by Wall St. Rank hold APYX as of Q4 2017.

  • Emerald Mutual Fund Advisers Trust reported no remaining Apyx Medical position as of Q4 2017 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 490,000 Apyx Medical shares in Q4 2017, an estimated $1.66M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Apyx Medical in Q4 2016 and held it in 4 quarters.
  • Emerald Mutual Fund Advisers Trust's Apyx Medical position peaked at $1.79M in Q4 2016.
  • 41 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2017.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2017, filed 6 Feb 2018.